Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
05/03/2025 13:32
March 5 (Reuters) - TC Biopharm (Holdings) PLC T0Uy.F: TCBP ANNOUNCES NON-BINDING LETTER OF INTENT TO ACQUIRE COMMERCIAL STAGE OPHTHALMIC PHARMACEUTICAL COMPANY TC BIOPHARM (HOLDINGS) PLC - TO ACQUIRE COMMERCIAL-STAGE OPHTHALMIC PHARMACEUTICAL COMPANY IN ALL-STOCK TRANSACTION Source text: ID:nPn8Vnbfya Further company coverage: [T0Uy.F] (Reuters.Briefs@thomsonreuters.com)
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange